查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830801

2025年全球體外大腸直腸癌篩檢市場報告

In-vitro Colorectal Cancer Screening Tests Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，體外大腸直腸癌篩檢市場規模呈現強勁成長勢頭，從2024年的12.1億美元增加至2025年的13億美元，複合年成長率達7.4%。這一歷史性成長可歸因於人們對早期癌症檢測認知的不斷提高、政府篩檢項目的擴展、非侵入性檢測方法的日益普及、醫療保健支出的不斷成長以及家用篩檢套件的普及。

預計未來幾年體外大腸直腸癌篩檢市場將強勁成長，到2029年將達到17.1億美元，複合年成長率為7.0%。預測期內的成長可歸因於對個人化醫療的日益關注、對經濟高效診斷方法的需求不斷成長、癌症研究投資的不斷擴大、分子診斷技術的日益普及、結直腸癌患病率的上升以及新興市場檢測可及性的提高。預測期內的主要趨勢包括液態切片技術的進步、生物標記發現的創新、人工智慧在檢測分析中的整合、多目標糞便去氧核糖核酸檢測的開發、樣本採集和處理的創新、自動化和數位病理學的進步以及雲端基礎診斷平台的普及。

體外大腸直腸癌篩檢是一種非侵入性的實驗室檢測，透過檢查糞便或血液樣本來識別大腸直腸癌和癌前病變的指標。這些檢測能夠在無症狀個體中早期發現大腸直腸癌，從而促進及時干預並降低癌症相關死亡率。

體外大腸直腸癌篩檢測試的主要類型包括大便潛血試驗、糞便去氧核糖核酸(DNA) 測試和血液生物標記測試。大便潛血試驗是一種非侵入性診斷方法，用於檢測糞便中的隱藏（潛血），這可能表明早期大腸直腸癌或其他胃腸道疾病。各種影像診斷技術，包括大腸鏡檢查、肛門鏡檢查、電腦斷層掃描 (CT)、超音波、超音波磁振造影(MRI) 和正子斷層掃描 (PET)，支援廣泛的應用，包括篩檢、診斷、監測、風險評估和治療後監測。這些測試和技術服務於各種最終用戶，包括醫院、診斷實驗室、門診、居家照護機構和研究機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦嚴重影響了醫療保健產業，尤其是關鍵醫療設備、診斷設備和藥品的供應。醫院和醫療機構面臨進口手術器械、影像設備以及注射器和導管等消耗品成本上漲的問題。這些成本上漲給醫療保健預算帶來了巨大壓力，導致一些醫療機構推遲設備升級或將成本轉嫁給患者。此外，原料和零件的關稅阻礙了基本藥品和醫療設備的生產，造成了供應鏈瓶頸。為此，該行業正在籌資策略多元化，盡可能促進本地生產，並倡導對緊急醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供體外結直腸癌篩檢篩檢市場統計數據，包括全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的體外結直腸癌篩檢測試細分市場、市場趨勢和機遇，以及您在體外結直腸癌篩檢測試行業取得成功所需的數據。本體外結直腸癌篩檢測試市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的全方位觀點。

預計未來幾年，大腸直腸癌盛行率的上升將推動試管內腸癌篩檢市場的成長。大腸直腸癌是一種發生於結腸或直腸的癌症，通常由癌前息肉發展而來。大腸直腸癌發生率的上升很大程度上與不健康的生活方式有關，因為不良飲食、缺乏運動和肥胖會增加息肉形成和癌症發展的風險。試管內結直腸癌篩檢試驗透過提供一種非侵入性方法，在早期階段檢測癌症，從而支持早期診斷。這些試驗透過先進的生物標記檢測提高了篩檢的準確性，從而能夠及時干預並改善患者預後。例如，根據美國非營利組織美國癌症協會的數據，預計2025年2月結直腸癌新病例數將從2024年的152,810例增加到154,270例。因此，大腸直腸癌發生率的上升刺激了試管內直腸癌篩檢測試市場的擴張。

試管內腸癌篩檢市場的公司正專注於開發先進的診斷解決方案，例如多目標糞便 DNA 檢測，以提高早期發現率、方便患者並降低大腸癌死亡率。多目標糞便 DNA 檢測是一種創新的篩檢工具，可分析糞便樣本中與大腸癌和癌前病變相關的基因和生化標記。例如，2025 年 3 月，美國分子診斷公司 Exact Sciences Corp. 推出了 Cologuard Plus，這是一款針對 45 歲及以上平均風險成年人的增強型家用大腸癌篩檢測試。該測試結合了先進的生物標記技術，比傳統測試具有更高的靈敏度和特異性。該測試使用複雜的演算法來檢測 DNA 突變和血紅蛋白生物標記物，從而提高了大腸直腸癌和晚期腺瘤的檢測率。 Cologuard Plus 提供了一種非侵入性且便捷的篩檢選項，無需使用抗腸道藥物或飲食限制，從而提高了患者對建議篩檢指南的依從性。

2025年2月，德國生技公司Mainz Biomed NV與Labor Team W AG合作推出ColoAlert。此次合作旨在利用Labor Team W AG的診斷網路，並擴大ColoAlert在瑞士全境的覆蓋範圍，從而提高大腸直腸癌的早期發現率，並改善患者預後。 Labor Team W AG是一家總部位於瑞士的診斷服務公司，專注於體外大腸癌篩檢。

體外結直腸癌篩檢測試市場由提供分子診斷測試、實驗室樣本採集和處理服務、風險評估和遺傳諮詢服務、遠端醫療醫療篩檢諮詢、醫療營業單位篩檢專案管理以及電子健康記錄(EHR) 整合服務等服務的實體所獲得的收入組成。市場價值包括服務提供者銷售的或包含在其服務產品中的任何相關產品的收益。試管內大腸直腸癌篩檢測試市場還包括樣本採集設備、自動篩檢設備、樣本儲存和運輸系統以及數位診斷平台的銷售。該市場的價值是“出廠價”，即產品製造商或創造者銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的產品價值。該市場中的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球體外大腸直腸癌篩檢測試：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球體外大腸直腸癌篩檢測試市場：成長率分析
  • 全球體外大腸直腸癌篩檢測試市場表現：規模與成長，2019-2024
  • 全球體外大腸直腸癌篩檢測試市場預測：規模與成長，2024-2029年，2034年
  • 全球體外大腸直腸癌篩檢測試：總目標市場（TAM）

第6章 市場細分

  • 全球體外大腸直腸癌篩檢市場（按檢測類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 大便潛血試驗
  • 糞便去氧核糖核酸檢測
  • 血液生物標記檢測
  • 其他測試類型
  • 全球體外大腸直腸癌篩檢市場（按影像類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 大腸鏡檢查
  • 直腸鏡檢查
  • 電腦斷層掃描
  • 超音波
  • 磁振造影
  • 正子斷層掃描
  • 全球體外大腸直腸癌篩檢市場：應用、績效及預測（2019-2024年、2024-2029年及2034年）
  • 篩檢
  • 診斷
  • 監控
  • 風險評估
  • 治療後監測
  • 全球體外大腸直腸癌篩檢市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷實驗室
  • 門診
  • 居家照護環境
  • 研究機構
  • 全球體外大腸直腸癌篩檢測試市場：糞便大便潛血試驗細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 癒創木脂大便潛血試驗
  • 免疫化學大便潛血試驗
  • 全球體外大腸直腸癌篩檢測試市場：糞便去氧核糖核酸檢測細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 單項糞便去氧核糖核酸檢測
  • 多目標糞便去氧核糖核酸檢測
  • 全球體外大腸直腸癌篩檢測試市場：依血液生物標記測試（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 甲基化septin 9去氧核糖核酸檢測
  • 循環腫瘤去氧核糖核酸檢測
  • 基於蛋白質生物標記的血液檢測
  • 全球體外大腸直腸癌篩檢測試市場：依測試類型（其他）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 尿液生物標記檢測
  • 基於血清的生物標記檢測
  • 呼吸揮發性有機化合物測試

第7章 區域和國家分析

  • 全球體外大腸直腸癌篩檢檢測市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球體外大腸癌篩檢市場：依國家、地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 體外大腸直腸癌篩檢測試市場：競爭格局
  • 體外大腸直腸癌篩檢測試市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Roche Diagnostics International AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Illumina Inc.
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Exact Sciences Corporation
  • Natera Inc.
  • Leica Biosystems Nussloch GmbH
  • BGI Genomics Co. Ltd.
  • NeoGenomics Inc.
  • Guardant Health Inc.
  • CellMax Life Inc.
  • Epigenomics AG
  • Acuamark Diagnostics Inc.
  • Beacon Biomedical Inc.
  • Mainz Biomed NV

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年體外大腸直腸癌篩檢測試市場：提供新機會的國家
  • 2029年體外大腸直腸癌篩檢測試市場：細分市場帶來新機會
  • 2029年體外大腸直腸癌篩檢市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37790

In-vitro colorectal cancer screening tests are non-invasive, laboratory-based tests that examine stool or blood samples to identify indicators of colorectal cancer or precancerous conditions. These tests enable early detection of colorectal cancer in asymptomatic individuals, facilitating timely intervention and reducing cancer-related mortality.

The primary types of in-vitro colorectal cancer screening tests include the fecal occult blood test, stool deoxyribonucleic acid (DNA) test, blood biomarker test, and others. The fecal occult blood test is a non-invasive diagnostic method used to detect hidden (occult) blood in the stool, which may indicate early colorectal cancer or other gastrointestinal disorders. Various imaging techniques, including colonoscopy, proctoscopy, computed tomography (CT) scans, ultrasound, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans, support a wide range of applications such as screening, diagnosis, monitoring, risk assessment, and post-treatment surveillance. These tests and techniques serve a variety of end users, including hospitals, diagnostic laboratories, outpatient clinics, home care settings, and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The in-vitro colorectal cancer screening tests market research report is one of a series of new reports from The Business Research Company that provides in-vitro colorectal cancer screening tests market statistics, including in-vitro colorectal cancer screening tests industry global market size, regional shares, competitors with a in-vitro colorectal cancer screening tests market share, detailed in-vitro colorectal cancer screening tests market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro colorectal cancer screening tests industry. This in-vitro colorectal cancer screening tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in-vitro colorectal cancer screening tests market size has grown strongly in recent years. It will grow from $1.21 billion in 2024 to $1.30 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period can be attributed to rising awareness of early cancer detection, the expansion of government screening programs, increased adoption of non-invasive testing methods, growing healthcare expenditure, and greater availability of at-home screening kits.

The in-vitro colorectal cancer screening tests market size is expected to see strong growth in the next few years. It will grow to $1.71 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth during the forecast period can be attributed to an increasing focus on personalized medicine, rising demand for cost-effective diagnostics, growing investments in cancer research, expanding adoption of molecular diagnostic techniques, increasing prevalence of colorectal cancer, and greater accessibility of testing in emerging markets. Major trends expected in the forecast period include advancements in liquid biopsy technologies, innovations in biomarker discovery, integration of artificial intelligence in test analysis, development of multi-target stool deoxyribonucleic acid tests, innovations in sample collection and processing, progress in automation and digital pathology, and the adoption of cloud-based diagnostic platforms.

The rising prevalence of colorectal cancer is expected to drive growth in the in vitro colorectal cancer screening tests market in the coming years. Colorectal cancer is a type of cancer that originates in the colon or rectum, often developing from precancerous polyps. The increasing incidence of colorectal cancer is largely linked to unhealthy lifestyle habits, as poor diet, physical inactivity, and obesity elevate the risk of polyp formation and cancer development. In vitro colorectal cancer screening tests support early diagnosis by providing non-invasive methods to detect cancer at initial stages. These tests enhance screening accuracy through advanced biomarker detection, enabling timely intervention and improved patient outcomes. For example, in February 2025, according to the American Cancer Society, a US-based nonprofit organization, the estimated number of new colorectal cancer cases reached 154,270, up from 152,810 cases in 2024. Therefore, the rising prevalence of colorectal cancer is fueling the expansion of the in vitro colorectal cancer screening tests market.

Companies in the in vitro colorectal cancer screening tests market are focusing on developing advanced diagnostic solutions, such as multi-target stool DNA tests, to improve early detection, enhance patient convenience, and reduce colorectal cancer mortality. Multi-target stool DNA tests are innovative screening tools that analyze stool samples for genetic and biochemical markers linked to colorectal cancer and precancerous lesions. For instance, in March 2025, Exact Sciences Corp., a US-based molecular diagnostics company, introduced Cologuard Plus, an enhanced at-home colorectal cancer screening test for average-risk adults aged 45 and older. This test incorporates advanced biomarker technology to deliver higher sensitivity and specificity than its predecessor. It uses a refined algorithm to detect DNA mutations and hemoglobin biomarkers, improving detection of both colorectal cancer and advanced adenomas. Cologuard Plus offers a non-invasive, convenient screening option that eliminates the need for bowel preparation or dietary restrictions, thereby improving patient adherence to recommended screening guidelines.

In February 2025, Mainz Biomed N.V., a Germany-based biotech company, partnered with Labor Team W AG to launch ColoAlert. This collaboration aims to expand the availability of ColoAlert across Switzerland, leveraging Labor Team W AG's diagnostic network to enhance early colorectal cancer detection and improve patient outcomes. Labor Team W AG is a Switzerland-based diagnostic services company specializing in in vitro colorectal cancer screening tests.

Major players in the in-vitro colorectal cancer screening tests market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Quest Diagnostics Incorporated, Roche Diagnostics International AG, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Natera Inc., Leica Biosystems Nussloch GmbH, BGI Genomics Co. Ltd., NeoGenomics Inc., Guardant Health Inc., CellMax Life Inc., Epigenomics AG, Acuamark Diagnostics Inc., Beacon Biomedical Inc., Mainz Biomed NV.

North America was the largest region in the in-vitro colorectal cancer screening tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in in-vitro colorectal cancer screening tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the in-vitro colorectal cancer screening tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in-vitro colorectal cancer screening tests market consists of revenues earned by entities by providing services such as molecular diagnostic testing, lab sample collection and processing services, risk assessment and genetic counseling services, telehealth-based screening consultations, screening program management for institutions, and electronic health record (EHR) integration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The in vitro colorectal cancer screening tests market also includes sales of sample collection devices, automated screening instruments, sample preservation and transport systems, and digital diagnostic platforms. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-vitro Colorectal Cancer Screening Tests Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in-vitro colorectal cancer screening tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro colorectal cancer screening tests ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in-vitro colorectal cancer screening tests market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Fecal Occult Blood Test; Stool Deoxyribonucleic Acid Test; Blood Biomarker Test; Other Test Types
  • 2) By Imaging Type: Colonoscopy; Proctoscopy; Computed Tomography Scan; Ultrasound; Magnetic Resonance Imaging; Positron Emission Tomography Scan
  • 3) By Application: Screening; Diagnosis; Monitoring; Risk Assessment; Post-Treatment Surveillance
  • 4) By End User: Hospitals; Diagnostic Laboratories; Outpatient Clinics; Home Care Settings; Research Institutions
  • Subsegments:
  • 1) By Fecal Occult Blood Test: Guaiac Based Fecal Occult Blood Test; Immunochemical Fecal Occult Blood Test
  • 2) By Stool Deoxyribonucleic Acid Test: Single Target Stool Deoxyribonucleic Acid Test; Multi Target Stool Deoxyribonucleic Acid Test
  • 3) By Blood Biomarker Test: Methylated Septin 9 Deoxyribonucleic Acid Test; Circulating Tumor Deoxyribonucleic Acid Test; Protein Biomarker Based Blood Test
  • 4) By Other Test Types: Urine Based Biomarker Test; Serum Based Biomarker Test; Breath Based Volatile Organic Compound Test
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers; Quest Diagnostics Incorporated; Roche Diagnostics International AG; Illumina Inc.; Sysmex Corporation; Bio-Rad Laboratories Inc.; Qiagen N.V.; Exact Sciences Corporation; Natera Inc.; Leica Biosystems Nussloch GmbH; BGI Genomics Co. Ltd.; NeoGenomics Inc.; Guardant Health Inc.; CellMax Life Inc.; Epigenomics AG; Acuamark Diagnostics Inc.; Beacon Biomedical Inc.; Mainz Biomed NV
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In-vitro Colorectal Cancer Screening Tests Market Characteristics

3. In-vitro Colorectal Cancer Screening Tests Market Trends And Strategies

4. In-vitro Colorectal Cancer Screening Tests Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global In-vitro Colorectal Cancer Screening Tests Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In-vitro Colorectal Cancer Screening Tests PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In-vitro Colorectal Cancer Screening Tests Market Growth Rate Analysis
  • 5.4. Global In-vitro Colorectal Cancer Screening Tests Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In-vitro Colorectal Cancer Screening Tests Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In-vitro Colorectal Cancer Screening Tests Total Addressable Market (TAM)

6. In-vitro Colorectal Cancer Screening Tests Market Segmentation

  • 6.1. Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fecal Occult Blood Test
  • Stool Deoxyribonucleic Acid Test
  • Blood Biomarker Test
  • Other Test Types
  • 6.2. Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Colonoscopy
  • Proctoscopy
  • Computed Tomography Scan
  • Ultrasound
  • Magnetic Resonance Imaging
  • Positron Emission Tomography Scan
  • 6.3. Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Screening
  • Diagnosis
  • Monitoring
  • Risk Assessment
  • Post-Treatment Surveillance
  • 6.4. Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Outpatient Clinics
  • Home Care Settings
  • Research Institutions
  • 6.5. Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Fecal Occult Blood Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Guaiac Based Fecal Occult Blood Test
  • Immunochemical Fecal Occult Blood Test
  • 6.6. Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Stool Deoxyribonucleic Acid Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Target Stool Deoxyribonucleic Acid Test
  • Multi Target Stool Deoxyribonucleic Acid Test
  • 6.7. Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Blood Biomarker Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Methylated Septin 9 Deoxyribonucleic Acid Test
  • Circulating Tumor Deoxyribonucleic Acid Test
  • Protein Biomarker Based Blood Test
  • 6.8. Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Based Biomarker Test
  • Serum Based Biomarker Test
  • Breath Based Volatile Organic Compound Test

7. In-vitro Colorectal Cancer Screening Tests Market Regional And Country Analysis

  • 7.1. Global In-vitro Colorectal Cancer Screening Tests Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In-vitro Colorectal Cancer Screening Tests Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market

  • 8.1. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In-vitro Colorectal Cancer Screening Tests Market

  • 9.1. China In-vitro Colorectal Cancer Screening Tests Market Overview
  • 9.2. China In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In-vitro Colorectal Cancer Screening Tests Market

  • 10.1. India In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In-vitro Colorectal Cancer Screening Tests Market

  • 11.1. Japan In-vitro Colorectal Cancer Screening Tests Market Overview
  • 11.2. Japan In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In-vitro Colorectal Cancer Screening Tests Market

  • 12.1. Australia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In-vitro Colorectal Cancer Screening Tests Market

  • 13.1. Indonesia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In-vitro Colorectal Cancer Screening Tests Market

  • 14.1. South Korea In-vitro Colorectal Cancer Screening Tests Market Overview
  • 14.2. South Korea In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In-vitro Colorectal Cancer Screening Tests Market

  • 15.1. Western Europe In-vitro Colorectal Cancer Screening Tests Market Overview
  • 15.2. Western Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In-vitro Colorectal Cancer Screening Tests Market

  • 16.1. UK In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In-vitro Colorectal Cancer Screening Tests Market

  • 17.1. Germany In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In-vitro Colorectal Cancer Screening Tests Market

  • 18.1. France In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In-vitro Colorectal Cancer Screening Tests Market

  • 19.1. Italy In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In-vitro Colorectal Cancer Screening Tests Market

  • 20.1. Spain In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market

  • 21.1. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market Overview
  • 21.2. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In-vitro Colorectal Cancer Screening Tests Market

  • 22.1. Russia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In-vitro Colorectal Cancer Screening Tests Market

  • 23.1. North America In-vitro Colorectal Cancer Screening Tests Market Overview
  • 23.2. North America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In-vitro Colorectal Cancer Screening Tests Market

  • 24.1. USA In-vitro Colorectal Cancer Screening Tests Market Overview
  • 24.2. USA In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In-vitro Colorectal Cancer Screening Tests Market

  • 25.1. Canada In-vitro Colorectal Cancer Screening Tests Market Overview
  • 25.2. Canada In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In-vitro Colorectal Cancer Screening Tests Market

  • 26.1. South America In-vitro Colorectal Cancer Screening Tests Market Overview
  • 26.2. South America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In-vitro Colorectal Cancer Screening Tests Market

  • 27.1. Brazil In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In-vitro Colorectal Cancer Screening Tests Market

  • 28.1. Middle East In-vitro Colorectal Cancer Screening Tests Market Overview
  • 28.2. Middle East In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In-vitro Colorectal Cancer Screening Tests Market

  • 29.1. Africa In-vitro Colorectal Cancer Screening Tests Market Overview
  • 29.2. Africa In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In-vitro Colorectal Cancer Screening Tests Market Competitive Landscape And Company Profiles

  • 30.1. In-vitro Colorectal Cancer Screening Tests Market Competitive Landscape
  • 30.2. In-vitro Colorectal Cancer Screening Tests Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Roche Diagnostics International AG Overview, Products and Services, Strategy and Financial Analysis

31. In-vitro Colorectal Cancer Screening Tests Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Sysmex Corporation
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. Qiagen N.V.
  • 31.5. Exact Sciences Corporation
  • 31.6. Natera Inc.
  • 31.7. Leica Biosystems Nussloch GmbH
  • 31.8. BGI Genomics Co. Ltd.
  • 31.9. NeoGenomics Inc.
  • 31.10. Guardant Health Inc.
  • 31.11. CellMax Life Inc.
  • 31.12. Epigenomics AG
  • 31.13. Acuamark Diagnostics Inc.
  • 31.14. Beacon Biomedical Inc.
  • 31.15. Mainz Biomed NV

32. Global In-vitro Colorectal Cancer Screening Tests Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In-vitro Colorectal Cancer Screening Tests Market

34. Recent Developments In The In-vitro Colorectal Cancer Screening Tests Market

35. In-vitro Colorectal Cancer Screening Tests Market High Potential Countries, Segments and Strategies

  • 35.1 In-vitro Colorectal Cancer Screening Tests Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 In-vitro Colorectal Cancer Screening Tests Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 In-vitro Colorectal Cancer Screening Tests Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer